Latanoprost
Latanoprost is a prostaglandin F2-alpha analogue. It works by increasing the natural outflow of aqueous humor (fluid) from the eye, thereby lowering intraocular pressure and reducing the risk of optic nerve damage in glaucoma patients.
Dosage by Body Weight
The standard dose is one drop in the affected eye(s) once daily in the evening. Do not exceed once-daily dosing, as more frequent administration may decrease the pressure-lowering effect.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy in infants under 1 year of age have not been established.
- Body Weight
- 5-7 kg
- Dose
- 1 drop in the affected eye(s)
- Frequency
- Once daily in the evening
- Tracking Notes
- Ophthalmic dosing is not determined by body weight. Use only if explicitly prescribed by a pediatric ophthalmologist.
- Body Weight
- 8-10 kg
- Dose
- 1 drop in the affected eye(s)
- Frequency
- Once daily in the evening
- Tracking Notes
- Ophthalmic dosing is not determined by body weight. Use only under medical supervision.
- Body Weight
- 11-15 kg
- Dose
- 1 drop in the affected eye(s)
- Frequency
- Once daily in the evening
- Tracking Notes
- Ophthalmic dosing is not determined by body weight. Standard localized ocular therapy applies.
- Body Weight
- 16-20 kg
- Dose
- 1 drop in the affected eye(s)
- Frequency
- Once daily in the evening
- Tracking Notes
- Ophthalmic dosing is not determined by body weight. Standard localized ocular therapy applies.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | N/A | Safety and efficacy in infants under 1 year of age have not been established. |
| 5-7 kg | 1 drop in the affected eye(s) | Once daily in the evening | Ophthalmic dosing is not determined by body weight. Use only if explicitly prescribed by a pediatric ophthalmologist. |
| 8-10 kg | 1 drop in the affected eye(s) | Once daily in the evening | Ophthalmic dosing is not determined by body weight. Use only under medical supervision. |
| 11-15 kg | 1 drop in the affected eye(s) | Once daily in the evening | Ophthalmic dosing is not determined by body weight. Standard localized ocular therapy applies. |
| 16-20 kg | 1 drop in the affected eye(s) | Once daily in the evening | Ophthalmic dosing is not determined by body weight. Standard localized ocular therapy applies. |
Formulation
Purpose
Used to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Generic Name
LatanoprostBranded Drug Names
Latanoprost is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:
Scheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.